Cadre Holdings Inc (CDRE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cadre Holdings inc   (NYSE: CDRE)


Cadre Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cadre Holdings Inc's ROI in the second quarter of 2026?
Cadre Holdings inc achieved a return on average invested assets (ROI) of 5.12 % in its second quarter of 2026, which is below Cadre Holdings Inc's average return on investment, which stands at 5.27%.

ROI fell compared to the first quarter of 2026, despite the net income growth of 477.57% from the first quarter of 2026.

Within the Healthcare sector 144 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1229 to 1532.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 20.96 % 29.79 % 25 % 34.21 % 39.69 %
Y / Y Net Income Change TTM -5.34 % -4.13 % 51.14 % 179.76 % 203.15 %
Investment (TTM) in Millions 730 739 666 686 688
Return On Investment (TTM) 5.12 % 5.31 % 6.78 % 7.27 % 6.54 %
CDRE's Overall Ranking # 1532 # 1229 # 886 # 989 # 985
Seq. Investment Change TTM 1.48 % 6.76 % 4.29 % 7.06 % 8.89 %
Seq. Net Income Change TTM -2.18 % -16.48 % -2.74 % 19.12 % -0.93 %
Net Income (TTM) in Millions 36 37 44 45 38

CDRE Company Profile >> Back to CDRE Roi Comparisons >> See Annual CDRE Return On Investment



Return On Investment CDRE's Ranking
Within: No.
Industry # 43
Sector # 145
Overall # 1532

Return On Investment Statistics
High Average Low
11.72 %
5.27 %
-9.45 %
(Dec 31 2023)   (Sep 30 2021)







Financial Statements
Cadre Holdings Inc's II. Quarter Investments $ 730 Millions CDRE's Balance sheet
Cadre Holdings Inc's II. Quarter Income $ 11 Millions Quarterly CDRE's Income Statement
CDRE's Income by Division See CDRE's Income by Division


CDRE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 666 559 336 313 236
Y / Y Investment Growth 19.15 % 66.26 % 7.33 % 32.71 % -
Net Income in Millions 44 36 39 6 13
Y / Y Net Income Growth 22.16 % -6.49 % 563.93 % -54.03 % -
Annual Return On Investment 6.63 % 6.47 % 11.5 % 1.86 % 5.37 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 6.63 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDRE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDRE's Competitors
Subscribers only: Roi for Cadre Holdings Inc's Suppliers
Subscribers only: Return On Investment for CDRE's Customers

Other Ratios
CDRE's Roa CDRE's Inventory Turnover Ratio CDRE's Growth Rates CDRE's Dividend Statistics
CDRE's Profitability Ratios CDRE's Asset Turnover Ratio CDRE's Dividend Growth
CDRE's Roe CDRE's Valuation Ratios CDRE's Financial Strength Ratios CDRE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %

Date modified: 2026-09-11T10:05:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.